Leukemia

Aggressive Treatment Offers Striking Improvement in Infants with Acute Disease

Published in Cancer Weekly, November 7th, 2000

Infants with acute leukemia do not have as favorable a prognosis with conventional chemotherapy as older children. A study suggests that high-dose chemotherapy (HDC) with stem cell transplantation can significantly reduce relapse and improve survival in infants with acute leukemia.

The research was reported in the Journal of Clinical Oncology.

In the past, physicians have relied on traditional doses of chemotherapy to treat infants afflicted with leukemia, prescribing HDC to very few of them because of fear of toxicity. But the new study, the largest of its kind, concluded that HDC is safe and beneficial if offered within four months of a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2000-11-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry